1. Home
  2. HMC vs ONC Comparison

HMC vs ONC Comparison

Compare HMC & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honda Motor Company Ltd.

HMC

Honda Motor Company Ltd.

HOLD

Current Price

$31.58

Market Cap

36.2B

ML Signal

HOLD

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$347.48

Market Cap

40.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMC
ONC
Founded
1946
2010
Country
Japan
Switzerland
Employees
N/A
12000
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.2B
40.6B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
HMC
ONC
Price
$31.58
$347.48
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
N/A
$385.10
AVG Volume (30 Days)
1.1M
392.3K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
4.45%
N/A
EPS Growth
N/A
140.43
EPS
N/A
0.31
Revenue
N/A
$238,387,000.00
Revenue This Year
N/A
$723.76
Revenue Next Year
$4.36
$15.04
P/E Ratio
$40.40
$1,148.32
Revenue Growth
N/A
22179.16
52 Week Low
$23.25
$253.95
52 Week High
$34.89
$385.22

Technical Indicators

Market Signals
Indicator
HMC
ONC
Relative Strength Index (RSI) 65.48 64.05
Support Level $29.29 $325.47
Resistance Level $31.53 $353.10
Average True Range (ATR) 0.49 7.80
MACD 0.04 1.70
Stochastic Oscillator 80.48 65.02

Price Performance

Historical Comparison
HMC
ONC

About HMC Honda Motor Company Ltd.

Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.4 million light vehicles and 22.1 million motorcycles in fiscal 2026, and consolidated sales were JPY 21.8 trillion. Automobiles constitute 64% of revenue and motorcycles 18%, with the rest split between power products and financial services. Honda also makes robots and private jets.

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

Share on Social Networks: